Directed Evolution of Transcriptional Factor BreR for Improved Substrate Specificity Toward Deoxycholic Acid and Ursodeoxycholic Acid
Biotechnology Journal · 2025
DOI: 10.1002/biot.70058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2025. Verfasst von Jianping Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Glycoengineering Research Center, Shandong University, Qingdao, P. R. China. Hauptthemen laut MEDLINE: Deoxycholic Acid, Ursodeoxycholic Acid, Biosensing Techniques, Directed Molecular Evolution. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, SKLMT Frontiers and Challenges Project.
Abstract (Originalsprache)
Bile acids are endogenous organic acids in mammals that are crucial for digestion and human health. Diverse bile acids serve distinct roles in physiological processes. Deoxycholic acid (DCA) is acknowledged as a biomarker linked to liver and gallbladder disorders, while ursodeoxycholic acid (UDCA) serves as a therapeutic agent for gallstones and various biliary conditions. In this study, we developed a high‐throughput screening apparatus utilizing growth coupling and fluorescence sorting to evolve DCA biosensor BreR, and altered its major substrate‐binding site to yield mutant I125P, which significantly enhanced the specificity of its DCA response. Simultaneously, we evolved the BreR mutant in response to UDCA. The introduction of 50 mM UDCA resulted in a 235.7% rise in fluorescence intensity, so offering a novel technique for the expedited detection of UDCA. This work establishes an engineering strategy for reprogramming biosensor specificity and provides a foundational platform for UDCA biosensor deployment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Glycoengineering Research Center, Shandong University, Qingdao, P. R. China.
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.
- Zhejiang Key Laboratory of Medical Epigenetics, Institute of Aging Research, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, P. R. China.
ORCID-Profile: Qian Wang
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- SKLMT Frontiers and Challenges Project
- China Postdoctoral Science Foundation
Zitieren
APA
Xu, J., Zhang, J., Wang, X., Hao, Y., Wang, J., Su, B., Yin, J., Wang, Z., Wang, Q., & Qi, Q. (2025). Directed Evolution of Transcriptional Factor BreR for Improved Substrate Specificity Toward Deoxycholic Acid and Ursodeoxycholic Acid. Biotechnology Journal. https://doi.org/10.1002/biot.70058
Vancouver
Xu J, Zhang J, Wang X, Hao Y, Wang J, Su B, et al. Directed Evolution of Transcriptional Factor BreR for Improved Substrate Specificity Toward Deoxycholic Acid and Ursodeoxycholic Acid. Biotechnology Journal. 2025. doi:10.1002/biot.70058
BibTeX
@article{Xu2025,
author = {Xu, Jianping and Zhang, Jian and Wang, Xiaotong and Hao, Yue and Wang, Jinghai and Su, Baiyu and Yin, Jingyan and Wang, Zhiguo and Wang, Qian and Qi, Qingsheng},
title = {Directed Evolution of Transcriptional Factor BreR for Improved Substrate Specificity Toward Deoxycholic Acid and Ursodeoxycholic Acid},
journal = {Biotechnology Journal},
year = {2025},
doi = {10.1002/biot.70058}
}
EUVIMED